EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer-Reference-Cited by-同舟云学术

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer

Published:2008-12 Issue:6 Volume:10 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Pietersen Alexandra M,Horlings Hugo M,Hauptmann Michael,Langerød Anita,Ajouaou Abderrahim,Cornelissen-Steijger Paulien,Wessels Lodewijk F,Jonkers Jos,Vijver Marc J van de,van Lohuizen Maarten

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr2214.pdf

Reference46 articles.

1. Arnes JB, Collett K, Akslen LA: Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1. Histopathology. 2008, 52: 370-380. 10.1111/j.1365-2559.2007.02957.x.

2. Choi YL, Cho EY, Shin YK, Sung KW, Hwang YK, Lee SJ, Kong G, Lee JE, Kim JH, Yang JH, Nam SJ: Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients. Breast Cancer Res Treat. 2009, 113: 83-93. 10.1007/s10549-008-9909-4.

3. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA, Chinnaiyan AM: EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA. 2003, 100: 11606-11611. 10.1073/pnas.1933744100.

4. Raaphorst FM, Meijer CJ, Fieret E, Blokzijl T, Mommers E, Buerger H, Packeisen J, Sewalt RA, Otte AP, van Diest PJ: Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. Neoplasia. 2003, 5: 481-488.

5. Bachmann IM, Halvorsen OJ, Collett K, Stefansson IM, Straume O, Haukaas SA, Salvesen HB, Otte AP, Akslen LA: EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol. 2006, 24: 268-273. 10.1200/JCO.2005.01.5180.

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new digital droplet PCR method for looking at epigenetics in diffuse large B‐cell lymphomas: The role of BMI1, EZH2, and USP22 genes;International Journal of Laboratory Hematology;2024-09-10

2. TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are present;Human Pathology;2024-04

3. Switch-Independent 3A: An Epigenetic Regulator in Cancer with New Implications for Pulmonary Arterial Hypertension;Biomedicines;2023-12-20

4. Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility;British Journal of Cancer;2023-02-01

5. Polycomb-group proteins and epigenetic control of gene activity;Handbook of Epigenetics;2023